AKIN Criteria: Acute Kidney Injury After On-Pump Coronary Artery Bypass Graft (CABG)
- Conditions
- Kidney Failure
- Registration Number
- NCT00780845
- Lead Sponsor
- Hospital de Base
- Brief Summary
The purpose of this study is evaluate clinical outcomes and 30-day mortality after on-pump CABG.
- Detailed Description
Eight hundred and seventeen patients was enrolled in this series and divided into to groups: Group AKI (-) - patients without acute kidney injury after on-pump CABG. Group AKI (+) - patients with acute kidney injury after on-pump CABG. AKI was defined as an absolute increase in serum creatinine (SCr) of more than or equal to 0.3 mg/dl (≥ 26.4 μmol/l) or a percentage increase in SCr of more than or equal to 50% (1.5-fold from baseline). The change in SCr concentration was defined as the difference between immediate postoperative concentration and the highest concentration during the stay in ICU. Clinical Outcomes and 30-day mortality was evaluate in this patients.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 817
- Patients underwent on-pump coronary artery bypass grafting
- Patients with at least two serum creatinine values within 48 hours.
- Patients with end-stage kidney disease requiring renal replacement therapy.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To test the hypothesis that patients with acute kidney injury after on-pump CABG have higher 30-day mortality 30 days
- Secondary Outcome Measures
Name Time Method To compare clinical outcomes in patients with and without acute kidney injury after on-pump CABG 30 days